Clinical Trials Logo

Urinary Incontinence, Urge clinical trials

View clinical trials related to Urinary Incontinence, Urge.

Filter by:

NCT ID: NCT04270526 Completed - Overactive Bladder Clinical Trials

Minimizing Pain During Office Intradetrussor Botox Injection

Start date: August 15, 2020
Phase: Phase 4
Study type: Interventional

This will be a prospective double-blinded randomized controlled trial comparing two pre-treatment protocols for patients undergoing intradetrussor botox injections to determine if a buffered lidocaine solution offers superior pain control.

NCT ID: NCT04240613 Completed - Clinical trials for Urinary Incontinence, Urge

Tension-free Vaginal Tape Obturator for the Treatment of Urinary Incontinence -Long-term Follow-up

Start date: January 2004
Phase: N/A
Study type: Interventional

The efficacy of TVT-O (tension-free vaginal tape obturator) is well established in patients with stress urinary incontinence (SUI). The objective of this study was to evaluate the efficacy, safety and patient satisfaction of TVT-O in patients suffering from primary, mixed (MUI) or recurrent urinary incontinence (UI) in long-term follow-up.

NCT ID: NCT04211831 Completed - Clinical trials for Overactive Bladder With Urge Urinary Incontinence

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Start date: December 16, 2019
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy, safety, and tolerability of a single dose of URO-902 24 milligrams (mg) and 48 mg (administered via intradetrusor injection), compared with placebo, in participants with overactive bladder (OAB) and urge urinary incontinence (UUI) up to 48 weeks post-dose.

NCT ID: NCT04171531 Completed - Clinical trials for Urinary Incontinence, Stress

Sling vs Botox for Mixed Incontinence

MUSA
Start date: June 8, 2020
Phase: Phase 3
Study type: Interventional

The primary aim is to compare the effectiveness of intradetrusor injection of 100 unit injection of Botulinum toxin A to mid-urethral sling for change in MUI symptoms 6 months following treatment.

NCT ID: NCT04063852 Completed - Multiple Sclerosis Clinical Trials

PTNS on Urinary and Global Quality of Life in MS Patients

PTNSinMS
Start date: February 27, 2019
Phase:
Study type: Observational

This is a single-centered, prospective, longitudinal, observational cohort study of patients with MS who suffer from lower urinary tract symptoms (LUTS) and are refractory to two prior treatment modalities who have elected to pursue PTNS therapy for LUTS.

NCT ID: NCT04024085 Completed - Multiple Sclerosis Clinical Trials

Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis

Start date: March 13, 2019
Phase:
Study type: Observational

The aim of the study is to create a specific test to assess the global time required to go to the toilet and to perform micturition, at the moment the patient decides to urinate in multiple sclerosis population, and to assess its reliability.

NCT ID: NCT04016324 Completed - Overactive Bladder Clinical Trials

InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study

BASIC
Start date: November 28, 2019
Phase: N/A
Study type: Interventional

Post-market clinical follow-up for continued assessment of safety and performance of the InterStim basic evaluation lead and foramen needle(s) used during a therapy evaluation.

NCT ID: NCT03988569 Completed - Clinical trials for Pelvic Organ Prolapse

Enhanced Consent and Preparedness for Surgery Trial

ECAPS
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

To develop an audiovisual decision aid (AVDA) to improve the informed consent process. The investigators aim to examine the impact of a comprehensible AVDA that is written below the 8th grade reading level. The AVDA would be used for surgical consent compared to traditional verbal consent. Additionally, the investigators plan to determine whether this effect varies across the measured levels of health literacy of our patients.

NCT ID: NCT03841513 Completed - Clinical trials for Pelvic Organ Prolapse

Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence

MICRO
Start date: January 29, 2019
Phase: N/A
Study type: Interventional

This study evaluates the addition of a laparoscopic Burch colposuspension procedure at the time of laparoscopic sacrocolpopexy to prevent stress urinary incontinence. Half of the participants will undergo Burch colposuspension procedure at the time of sacrocolpopexy, and half of the participants will undergo sacrocolpopexy alone.

NCT ID: NCT03817931 Completed - Dementia Clinical Trials

Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

Start date: August 5, 2019
Phase: Phase 4
Study type: Interventional

Women presenting with overactive bladder symptoms will be randomized to one of 3 arms (anticholinergic, beta-3 agonist, placebo). They will undergo baseline cognitive testing, functional MRI of the brain. Cognitive testing and functional MRI will be repeated after taking their double blinded intervention for 30 days.